1. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
   Ling Wei et al, 2019, Molecular Cancer CrossRef
2. miR-326 down-regulate CYP19A1 expression and estradiol-17b production in buffalo granulosa cells through CREB and C/EBP-β
   Vaishali Chaurasiya et al, 2020, The Journal of Steroid Biochemistry and Molecular Biology CrossRef
3. MicroRNAs and Hepatocellular Carcinoma
   Aldo Cavallini, 2016, Hepatocellular Carcinoma CrossRef
4. MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway
   Ying Yang et al, 2021, Bioscience Reports CrossRef
5. Obesity-induced inflammatory miR-133a mediates apoptosis of granulosa cells and causes abnormal folliculogenesis
   Ruizhi Chen et al, 2023, Acta Biochimica et Biophysica Sinica CrossRef
6. Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs
   Bernhard Biersack, 2017, Non-coding RNA Research CrossRef
7. Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer
   Kangni Zou et al, 2022, Frontiers in Oncology CrossRef
8. Non-coding RNAs in drug resistance of head and neck cancers: A review
   Fengsheng Dai et al, 2020, Biomedicine & Pharmacotherapy CrossRef
9. miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers
   Hesham A. El-Mahdy et al, 2022, Pathology - Research and Practice CrossRef
10. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers
    Fatemeh Dashti et al, 2021, Molecular Therapy - Nucleic Acids CrossRef
11. 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
    Soudeh Ghafouri-Fard et al, 2021, Frontiers in Oncology CrossRef